Navigation Links
Ventas Appoints James D. Shelton and Robert D. Reed to Board
Date:3/5/2008

serves as a Senior Advisor to CCMP. Shelton previously served on the Board of the Federation of American Hospitals and the Board of the American Hospital Association. He has a BA from Louisiana State University and an MS from the Graduate School of Public Administration at the University of Missouri at Columbia.

Reed has served as Senior Vice President and Chief Financial Officer at Sutter Health, a family of not-for-profit hospitals and physicians organizations in northern California, since 1997. Prior to that, he held various finance positions within Sutter Health and its affiliates. Before becoming a non-for-profit hospital system executive, Reed was an investment banker specializing in healthcare finance for hospital systems at various national financial firms, including Eastdil, Paine Webber and American Health Capital. He is a member of the Board of Directors of Interplast, an international humanitarian organization that provides free reconstructive surgery in developing countries, and he sits on the Boards of Directors of Metta Fund and Personalized Physician Care, Inc. Reed earned a BA in economics from Rollins College.

Ventas, Inc. is a leading healthcare real estate investment trust. Its diverse portfolio of properties located in 43 states and two Canadian provinces includes seniors housing communities, skilled nursing facilities, hospitals and medical office and other properties. More information about Ventas can be found on its website at http://www.ventasreit.com.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding Ventas, Inc.'s ("Ventas" or the "Company") and its subsidiaries' expected future financial position, results of operations, cash flows, funds from operations, dividends and dividend plans, financin
'/>"/>

SOURCE Ventas, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ventas to Present at the Citi 2008 Global Property CEO Conference
2. Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69
3. Ventas Completes Previously Announced Sale of Common Stock
4. Ventas Enters Agreement to Sell Common Stock
5. Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance
6. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
7. Ventas Appoints Brush SVP - Senior Housing Development and Operations
8. Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call
9. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
10. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
11. Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...e-FirstCall/ -- The Providence Service,Corporatio...Norris, the Company,s,Chief Operating Officer, ha...ors. Mr. Norris, appointment fills the vacancy le...inger and returns the board to six members. Mr.,...d. , Mr. Norris, age 41, has been with Prov...
(Date:11/21/2008)...ovel technique to combat cancer, study says, ,...lgian researchers have discovered that some cancer...and this might lead to new treatments that starve ...ate, all cells in the body need to produce energy....s that requires oxygen. Compared with normal cells...
(Date:11/21/2008)...rously Protect Investment And Restore Shareholder ...SNewswire/ -- Dr. Stephen Joffe, Craig Joffe, and ...dule 13D with the U.S. Securities and Exchange Com...ing ownership of 11.4% of LCA-Vision, Inc. (Nasdaq... laser vision correction centers in 33 states in t...
(Date:11/21/2008)...re-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE:...rwhelmingly approved the proposals submitted to th...rmaceuticals Industries Ltd. (Nasdaq: TEVA ). ,...ing support of the transaction by the Barr shareho...CEO. "We are pleased with the progress that we con...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
...staurants and the flourishing livestock trade in B...ng the sale of beef and pork following an outbreak...tan government spokesperson said cases of the cont...pecies of cloven-hoofed animals were being reporte...
...ientists in the US have solved the structure of a ...ing that they say will help treat cardiac or neuro...r researchers at Brown University have solved the ...ein 97 (SAP97) found in abundance in the heart and...
...lignant mesothelioma is a very aggressive tumor wh...hich is increasing in frequency throughout the wor...of Malignant mesothelioma is exposure to asbestos,...40) is also found to be a causative agent for deve...
...udies in the past have shown that certain compound... growth of breast, prostate, colon and stomach can...bladder cancer. In a more recent study researchers... hindered the growth of bladder cancer cells in th...
Other Medicine News:Health News:Malignant Mesothelioma – A New Genetic Revelatio 2Health News:Malignant Mesothelioma – A New Genetic Revelatio 3
(Date:11/19/2008)...if., Nov. 19 Amgen,(Nas...Company, a subsidiary of,Takeda Pharmaceutical Co...nrollment in the Phase 3 MONET1 trial evaluating m... and carboplatin for the first-line treatment of,...en temporarily suspended,following a planned safe...
(Date:11/19/2008)...on Payment from Roche- , , MONTVALE, N.J., ...ticals Corp. (Nasdaq: MEMY ) today announced tha...e 2 trial of R3487/MEM 3454, its lead alpha-7 nico...sociated with schizophrenia (CIAS). The Company h...riggering a $5.0 million payment from its partner ...
(Date:11/18/2008)...ciation,s 2008 Faces of Influenza survey underscor...inst influenza; Mother and Gold Medalist Kristi Ya...ov. 18 While 78 percent of mothers...and potentially life-threatening disease that can ...milies will get vaccinated this season, according ...
(Date:11/12/2008)... 12 A new study being,p...ill help answer the,question, what causes Parkinso...in the medical research into,Parkinson,s disease i...die,in the first place. Answering this question ha...nearly identical types of brain cells that produce...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6A Window Into Parkinson's Disease 2Interleukin Genetics Announces Conversion of 242 04 Million of Debt Into Common Stock 2307 1Interleukin Genetics Announces Conversion of 242 04 Million of Debt Into Common Stock 2307 2Interleukin Genetics Announces Conversion of 242 04 Million of Debt Into Common Stock 2307 3Jingle bells not merry for tone deaf individuals 1679 1Jingle bells not merry for tone deaf individuals 1679 2Jingle bells not merry for tone deaf individuals 1679 3Drug aimed at 2 bioterror agents blocks live viral infection Weill Cornell team reports 1676 1Drug aimed at 2 bioterror agents blocks live viral infection Weill Cornell team reports 1676 2Drug aimed at 2 bioterror agents blocks live viral infection Weill Cornell team reports 1676 3St Jude finds link between cellular defense processes showing how cancer cells survive 8556 1St Jude finds link between cellular defense processes showing how cancer cells survive 8556 2St Jude finds link between cellular defense processes showing how cancer cells survive 8556 3
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: